Balyasny Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-169,343
| Closed | -$965K | – | 2112 |
|
|
2025
Q1 | $965K | Buy |
169,343
+88,600
| +110% | +$505K | ﹤0.01% | 1366 |
|
|
2024
Q4 | $793K | Buy |
80,743
+59,334
| +277% | +$583K | ﹤0.01% | 1353 |
|
|
2024
Q3 | $174K | Buy |
21,409
+8,317
| +64% | +$67.8K | ﹤0.01% | 1815 |
|
|
2024
Q2 | $175K | Buy |
+13,092
| New | +$175K | ﹤0.01% | 1721 |
|
|
2023
Q4 | – | Sell |
-786
| Closed | -$56.9K | – | 1984 |
|
|
2023
Q3 | $56.9K | Sell |
786
-20,852
| -96% | -$1.51M | ﹤0.01% | 1673 |
|
|
2023
Q2 | $1.61M | Buy |
21,638
+10,171
| +89% | +$757K | ﹤0.01% | 1082 |
|
|
2023
Q1 | $610K | Buy |
11,467
+10,490
| +1,074% | +$558K | ﹤0.01% | 1483 |
|
|
2022
Q4 | $66K | Buy |
+977
| New | +$66K | ﹤0.01% | 1871 |
|